[1]郭会利,叶艳君,李盼盼,等.云克静脉滴注联合活血通络方口服治疗 距骨骨软骨损伤的临床研究[J].中医正骨,2016,28(03):9-13.
　GUO Huili,YE Yanjun,LI Panpan,et al.Clinical study on intravenous drip of Yunke(云克)combined with oral application of Huoxue Tongluo Fang(活血通络方)for treatment of talar osteochondral injury[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):9-13.
点击复制

云克静脉滴注联合活血通络方口服治疗 距骨骨软骨损伤的临床研究()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第28卷
期数:
2016年03期
页码:
9-13
栏目:
临床研究
出版日期:
2016-03-20

文章信息/Info

Title:
Clinical study on intravenous drip of Yunke(云克)combined with oral application of Huoxue Tongluo Fang(活血通络方)for treatment of talar osteochondral injury
作者:
郭会利; 叶艳君; 李盼盼; 郭树农; 王军辉; 郭水洁
河南省洛阳正骨医院/河南省骨科医院,河南 洛阳 471002
Author(s):
GUO Huili; YE Yanjun; LI Panpan; GUO Shunong; WANG Junhui; GUO Shuijie
Luoyang Orthopedic-Traumatological Hospital,Luoyang 471002,Henan,China
关键词:
距骨;  踝关节;  锝;  亚甲基二膦酸盐;  中药疗法;  体层摄影术; 发射型计算机; 单光子;  体层摄影术; X线计算机;  图像融合;  治疗; 临床研究性
Keywords:
talus;  ankle joint;  technetium;  methylenediphosphonate;  drug therapy(TCD);  tomography; emission-computed; single-photon;  tomography; X-ray computed;  image fusion;  therapies; investigational
摘要:
目的:观察云克静脉滴注联合自拟活血通络方口服治疗距骨骨软骨损伤的临床疗效。方法:将75例距骨骨软骨损伤患者随机分为3组,每组25例,分别采用单纯静脉滴注云克、单纯口服自拟活血通络方及云克静脉滴注联合自拟活血通络方口服治疗。云克注射液静脉滴注每日1次,每分钟40滴,连续治疗30 d; 自拟活血通络方口服每日1剂,连续口服30 d。治疗结束后6个月采用自拟影像学评价标准、美国足与踝关节外科协会(American orthopaedic foot and ankle society,AOFAS)踝与后足功能评分标准及疼痛数字评价量表(numerical rating scale,NRS)评分法评定3组患者的临床疗效。结果:①踝关节NRS疼痛评分结果。治疗前3组患者踝关节NRS疼痛评分比较,差异无统计学意义[(3.000±0.577)分,(3.160±0.624)分,(3.080±0.759)分,F=0.369,P=0.693]。治疗结束后6个月,3组患者踝关节NRS疼痛评分比较,差异有统计学意义[(1.120±0.332)分,(1.640±0.757)分,(1.680±0.690)分,F=6.310,P=0.003]; 云克联合活血通络方组踝关节NRS疼痛评分低于云克组和活血通络方组(P=0.004,P=0.002); 云克组与活血通络方组比较,差异无统计学意义(P=0.821)。②踝关节AOFAS功能评分结果。云克联合活血通络方组1例患者自行退出试验。治疗结束后6个月,活血通络方组显效7例,有效10例,无效8例; 云克组显效9例,有效10例,无效6例; 云克联合活血通络方组显效15例,有效6例,无效3例。3组患者踝关节AOFAS功能评分比较,差异有统计学意义(χ2=6.316,P=0.043); 进一步两两比较(校正α'=0.025),云克联合活血通络方组优于活血通络方组(u=162.000,P=0.003); 云克组与云克联合活血通络方组、活血通络方组比较,差异均无统计学意义(u=218.000,P=0.045; u=251.000,P=0.232)。③影像学评价结果。3组均有患者拒绝影像学检查,其中活血通络方组2例、云克组2例、云克联合活血通络方组1例。治疗结束后6个月,活血通络方组显效4例,有效10例,无效9例; 云克组显效6例,有效9例,无效8例; 云克联合活血通络方组显效11例,有效10例,无效3例。3组患者影像学评价结果比较,差异有统计学意义(χ2=6.588,P=0.037); 进一步两两比较(校正α'=0.025),云克联合活血通络方组优于活血通络方组(u=99.000,P=0.018); 云克组与云克联合活血通络方组、活血通络方组比较,差异均无统计学意义(u=113.500,P=0.033; u=195.500,P=0.513)。结论:云克静脉滴注联合自拟活血通络方口服,能够缓解踝关节疼痛,改善踝关节功能,其综合疗效优于单纯口服自拟活血通络方,在缓解踝关节疼痛方面优于单纯静脉滴注云克和单纯口服自拟活血通络方,值得临床推广应用。
Abstract:
Objective:To observe the clinical curative effects of intravenous drip of Yunke(云克)combined with oral application of Huoxue Tongluo Fang(活血通络方,HXTLF)in the treatment of talar osteochondral injury.Methods:Seventy-five patients with talar osteochondral injury were randomly divided into 3 groups,25 cases in each group.The patients were treated with intravenous drip of Yunke(Yunke group,once a day for consecutive 30 days),oral application of self-made HXTLF(HXTLF group,one dose a day for consecutive 30 days)and combination therapy of intravenous drip of Yunke and oral application of self-made HXTLF(combination therapy group)respectively.The clinical curative effects were evaluated and compared between the 3 groups at 6 months after the end of the treatment by using self-designed radiographic evaluation criterion,ankle-hindfoot scale made by American orthopaedic foot and ankle society(AOFAS)and pain numerical rating scale(NRS).Results:There was no statistical difference in ankle NRS pain scores between the 3 groups before treatment(3.000+/-0.577,3.160+/-0.624,3.080+/-0.759 points,F=0.369,P=0.693).There was statistical difference in ankle NRS pain scores between the 3 groups at 6 months after the end of the treatment(1.120+/-0.332,1.640+/-0.757,1.680+/-0.690 points,F=6.310,P=0.003).The ankle NRS pain scores were lower in combination therapy group compared to Yunke group and HXTLF group(P=0.004,P=0.0020).There was no statistical difference in ankle NRS pain scores between Yunke group and HXTLF group(P=0.821).One patient dropped out in combination therapy group.Seven patients got a good result,10 fair and 8 poor in HXTLF group; 9 patients got a good result,10 fair and 6 poor in Yunke group; while 15 patients got a good result,6 fair and 3 poor in combination therapy group at 6 months after the end of the treatment.There was statistical difference in AOFAS ankle function scores between the 3 groups(χ2=6.316,P=0.043).Further pairwise comparison(α'=0.025)showed that combination therapy group surpassed HXTLF group(u=162.000,P=0.003)and there was no statistical difference between Yunke group and combination therapy group(u=218.000,P=0.045)and between Yunke group and HXTLF group(u=251.000,P=0.232)in AOFAS ankle function scores.Five patients refused radiographic examination.At 6 months after the end of the treatment,4 patients got a good result,10 fair and 9 poor in HXTLF group; 6 patients got a good result,9 fair and 8 poor in Yunke group; while 11 patients got a good result,10 fair and 3 poor in combination therapy group.There was statistical difference in radiographic evaluation results between the 3 groups(χ2=6.588,P=0.037).Further pairwise comparison(α'=0.025)showed that combination therapy group surpassed HXTLF group(u=99.000,P=0.018)and there was no statistical difference between Yunke group and combination therapy group(u=113.500,P=0.033)and between Yunke group and HXTLF group(u=195.500,P=0.513).Conclusion:Intravenous drip of Yunke combined with oral application of self-made HXTLF can relieve the ankle pain and improve the ankle function,and its comprehensive curative effect is better than that of monotherapy of oral application of self-made HXTLF,and it also surpasses the monotherapy of intravenous drip of Yunke and the monotherapy of oral application of self-made HXTLF in relieving ankle pain,so it is worthy of popularizing in clinic.

参考文献/References:

[1] 宋秀锋,郑加法,李宏志.成人距骨形态的解剖学研究[J].中国医药科学,2015,5(11):29-31.
[2] 赵斌,邢更彦.距骨骨软骨损伤的发病机制与诊断治疗[J].中国医学前沿杂志(电子版),2014,6(1):40-43.
[3] 徐杨俊,赵建宁.关节软骨损伤修复的研究进展[J].医学研究生学报,2010,23(8):889-894.
[4] Berndt AL,Harty M.Transchondral fractures(osteochondritis dissecans)of the talus[J].J Bone Joint Surg Am,2004,86-A(6):1336.
[5] Hepple S,Winson IG,Glew D.Osteochondral lesions of the talus:a revised classification[J].Foot Ankle Int,1999,20(20):789-793.
[6] 崔智慧,丁长青,孙迎迎,等.距骨骨软骨损伤的MRI表现[J].中国现代医生,2015,53(29):103-105.
[7] 郭会利,王军辉,郭树农,等.云克联合筋骨痛消丸治疗膝骨关节炎的临床研究[J].中医正骨,2013,25(6):24-28.
[8] 刘玉珂,张敏,郭会利等.应用图像融合技术评价肌肉骨骼系统的药物疗效——图像融合技术在骨与关节疾病诊断中的应用(八)[J].中医正骨,2011,23(4):24-29.
[9] 赵英.疼痛的测量和评估方法[J].中国临床康复,2002,6(16):2347-2349.
[10] 严广斌. AOFAS踝-后足评分系统[J].中华关节外科杂志(电子版),2014,8(4):557.
[11] 顾文奇,施忠民,柴益民.距骨骨软骨损伤治疗研究进展[J].国际骨科学杂志,2009,30(3):181-183.
[12] 裴正学,张桂琼.从恶性肿瘤的临床现状谈中西医结合的必要性[J].甘肃医药,2012,31(2):81-84.
[13] 刘思佳,孙占娟,周亚欧,等.99Tc-亚甲基二膦酸盐对胶原诱导性关节炎大鼠骨侵蚀的治疗作用[J].国际病理科学与临床杂志,2010,30(2):123-129.
[14] 陈洁,何跃,何成松.锝
[99Tc]亚甲基二膦酸盐注射液药理研究进展[J].中国药房,2010,29(6):553-555.
[15] 高克加,梅小刚,叶智卫,等.(99)Tc-MDP治疗与骨修复的试验研究[J].中国骨质疏松杂志,2015,21(7):827-831.

相似文献/References:

[1]鲁建作,林央央,杨杰,等.皮质骨螺钉内固定治疗下胫腓联合分离的CT研究[J].中医正骨,2015,27(11):13.
　LU Jianzuo,LIN Yangyang,YANG Jie,et al.Internal fixation with cortical bone screws for the treatment of distal tibiofibular syndesmosis separation:a CT study of 32 patients[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):13.
[2]茆军,张惠法,严培军,等.Ilizarov外固定支架结合克氏针固定治疗Pilon骨折[J].中医正骨,2015,27(10):32.
[3]戴国钢,刘剑伟,黄雷,等.运动员反复踝关节扭伤后继发足弓塌陷的原因探讨[J].中医正骨,2015,27(09):61.
[4]刘红娟,郭树农,叶艳君.云克静脉滴注联合中药薰洗治疗距骨缺血性坏死的护理[J].中医正骨,2015,27(06):79.
[5]李延红,石耀武,张宏蕾.外敷滑膜膏配合口服四妙丸治疗踝关节滑膜炎[J].中医正骨,2016,28(01):68.
[6]杨焱,丁长青,单素平.MRI检查在距骨骨挫伤诊断中的价值[J].中医正骨,2016,28(05):20.
[7]许秋群,赵英,何小琴.中医护理在三踝骨折围手术期的应用[J].中医正骨,2016,28(06):74.
[8]宋喜军,滕居赞.后外侧入路联合内侧入路切开复位内固定治疗踝关节骨折合并下胫腓联合分离[J].中医正骨,2016,28(11):53.
[9]向澍,顾健华.青鹏软膏膏摩法治疗陈旧性踝关节扭伤的临床研究[J].中医正骨,2017,29(08):33.
　XIANG Shu,GU Jianhua.Clinical study on rubbing therapy with Qingpeng(青鹏)ointment for treatment of old ankle sprain[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(03):33.
[10]孟丽娟,吴永磊,庞寅田,等.改良Ma-Griffith术联合下肢损伤薰洗方薰洗治疗闭合性跟腱断裂[J].中医正骨,2017,29(11):63.
[11]陈红浩,张春雷,窦浚峰,等.踝关节牵开成形术在距骨病变早期治疗中的应用价值[J].中医正骨,2019,31(10):66.

备注/Memo

备注/Memo:
基金项目:河南省中医药科学研究专项课题(2013ZY02046)
更新日期/Last Update: 2016-03-30